In this study, we investigated the outcome of co-transfecting PTEN and p53 tumor suppressors in SW480 CRC cells in vitro using recombinant CMV-plasmids carrying wild-type PTEN and p53 genes. This evidence concerns the gene TP53 and colorectal carcinoma.